More articles from Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Probes for Oncology

You have access
Comparison of SSTR2 agonist and antagonist peptides incorporating a novel ^99mTc-chelator for targeting neuroendocrine tumors
John Marquis, Kevin Maresca, Genliang Lu, Shawn Hillier, Craig Zimmerman, Jean Claude Reubi, Helmut Maecke, William Eckelman, John Joyal and John Babich

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 472;
You have access
Molecular imaging of CEACAM6 using antibody probes of different sizes
Gang Niu, Yanal Murad, Hao Gao, Orit Jacobson, Jianbing Zhang and Xiaoyuan Chen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 468;
You have access
Development of [18F]AlF-NOTA-RGD2 probe for microPET imaging in U87MG-tumor bearing mice
Shuanglong Liu, Hongguang Liu, Han Jiang and Zhen Cheng

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 524;
You have access
[^99mTc]labeled peptide targets the Met receptor tyrosine kinase (Met) in human gastric carcinoma (MKN 45) mouse xenografts
Elaine Jagoda, Sibaprasad Bhattacharyya, Joseph Kalen, Avrum Leeder, Lisa Riffle, Stephanie Histed, Donald Bottaro and P. Choyke

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 473;
You have access
Bifunctional chelates for 64Cu radiolabelling of BBN peptides for PET imaging, a comparative study
Veronique Dumulon-Perreault, Samia Ait-Mohand, Patrick Fournier, Garry Kiefer, Paul Jurek, Cara Ferreira and Brigitte Guerin

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 471;
You have access
Presenting a cell permeable peptide on a chelator scaffold for PET imaging of prostate cancer
Guiyang Hao, Ajay Singh, Crystal Gore, Rey-Chen Pong, Jer-Tsong Hsieh and Xiankai Sun

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 469;
You have access
Initial experience with reproducibility of tumor to background ratio in hypoxia PET imaging using the tracer [F-18] HX4
Shyam Srinivas, Kimberly Austin, Tami Kaczur and Frank DiFilippo

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 529;
You have access
Visualization of the endothelin (ET)-A receptor expression in papillary thyroid tumors using ET-A-receptor radioligands
Kristin Michel, Carsten Höltke, Katrin Büther, Olaf Prante, Otmar Schober, Michael Schafers, Stefan Wagner, Klaus Kopka, Burkhard Riemann and Simone Maschauer

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 526;
You have access
Comparison of lesion detection and characterisation in patients with neuroendocrine tumors using DOTATOC-PET in correlation with contrast-enhanced MRI and contrast-enhanced CT
Frederik Giesel, Christian Zechmann, Ali Afshar-Oromieh, Sarah Wulfert, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 528;
You have access
First human study of N-(2-(diethylamino)ethyl)-6-[F-18]fluoropyridine-3-carboxamide (MEL050)
Robert Ware, Damien Kee, Grant McArthur, Silvana Brglevska, Jason Callahan, Andrew Katsifis, Peter Roselt, Thomas Bourdier and Rodney Hicks

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 415;

Main menu

User menu

Search

More articles from Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Probes for Oncology

Pages